Trial intelligence / Profile preview

PK Interaction of Voriconazole with Clarithromycin

NCT05380245Phase 4Completed

Sponsor
Abdul Wali Khan University Mardan
Start
Nov 2018
Primary completion
Nov 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of voriconazole in fungal infection (2 arms), sponsored by Abdul Wali Khan University Mardan. Primary endpoints: Plasma Concentration of voriconazole at 24 hours and Area under the Plasma Concentration versus Time Curve at 24 hours. Started Nov 2018; status: completed.

02

Drugs

voriconazole
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT05380245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05380245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call